Explore the biosecurity landscape

See where this organization fits within the broader map of biosecurity work around the world.

View on the map

Vir Biotechnology

Company • www.vir.bio

Research Technology development

Vir Biotechnology is a clinical-stage biopharmaceutical company developing medicines for serious infectious diseases and cancer. Its current lead programmes focus on chronic hepatitis delta and oncology, with preclinical HIV-cure research, while its hepatitis B, influenza, COVID-19 and HPV programmes are available for partnering or out-licensing.

This company works on

  • Therapeutics
  • Vaccines